Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3679998 | 0.91 | CYP3A4 (0.52) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL3676678 | 0.87 | CYP3A4 (0.48) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL3677882 | 0.85 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL4298726 | 0.85 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL10454805 | 0.84 | CYP3A4 (0.41) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL2341640 | 0.81 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL23067652 | 0.79 | CYP3A4 (0.41) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL11865280 | 0.79 | GABRA1 (0.43) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL5576975 | 0.78 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL10661215 | 0.77 | CYP3A4 (0.40) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070141723-A1 | Immunohistochemistry staining controls | LAB VISION CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20060127956-A1 | Quality control for cytochemical assays | LAB VISION CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-7011940-B1 | Quality control for cytochemical assays | MEDICAL DISCOVERY PARTNERS LLC (US) | 2006-03-14 | — | — | US | disclosed |
| US-6855490-B2 | Method for attaching biological molecules to a glass surface | MEDICAL DISCOVERY PARTNERS LLC (US) | 2005-02-15 | — | — | US | disclosed |
| US-20030166261-A1 | Quality control for cytochemical assays | CYTOLOGIX CORPORATION | 2003-09-04 | — | — | US | disclosed |
| EP-1169643-A2 | QUALITY CONTROL FOR CYTOCHEMICAL ASSAYS | Cytologix Corporation (US) | 2002-01-09 | — | — | EP | disclosed |
| WO-2000062064-A2 | QUALITY CONTROL FOR CYTOCHEMICAL ASSAYS | CYTOLOGIX CORPORATION (US) | 2000-10-19 | — | — | WO | disclosed |
| US-4855504-A | Process for producing higher molecular weight amino compounds having reduced monomeric amine content | BAYER AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |